Maxamus Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.29 Cr
as on 13-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 2.37 Cr
as on 13-12-2024
- Revenue -10.67%
(FY 2016)
- Profit -58.40%
(FY 2016)
- Ebitda -5.79%
(FY 2016)
- Net Worth 4.67%
(FY 2016)
- Total Assets 5.09%
(FY 2016)
About Maxamus Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.29 Cr.
The company currently has active open charges totaling ₹2.37 Cr.
Pradeep Chawla and Vikas Bhatnagar serve as directors at the Company.
- CIN/LLPIN
U74900DL2010PTC198065
- Company No.
198065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2010
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Maxamus Pharma Private Limited offer?
Maxamus Pharma Private Limited offers a wide range of products and services, including Hair Care, Hair Growth Supplements, Skin Care, Bath Essentials, Facewash, Hair Growth for Men, Shampoo, Hair Conditioners, Women Care, Mother Care.
Who are the key members and board of directors at Maxamus Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Chawla  | Director | 15-Jan-2010 | Current |
| Vikas Bhatnagar | Director | 15-Jan-2010 | Current |
Financial Performance of Maxamus Pharma.
Maxamus Pharma Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 10.67% decrease. The company also saw a substantial fall in profitability, with a 58.4% decrease in profit. The company's net worth moved up by a moderate rise of 4.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxamus Pharma?
In 2016, Maxamus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 05 Aug 2013 | ₹0.85 M | Open |
Canara Bank Creation Date: 05 Aug 2013 | ₹0.37 M | Open |
Canara Bank Creation Date: 02 Nov 2012 | ₹2.25 Cr | Open |
How Many Employees Work at Maxamus Pharma?
Unlock and access historical data on people associated with Maxamus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxamus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxamus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
